This is much of interest to us, as husband Barry just started cabazitaxel with prednisone; we’re concerned about short and long-term effects of prednisone.
A preliminary report published in Journal of Cancer, August 2017, entitled ““Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer” studied 91 patients in Italy and showed median survival 9 months with prednisone and 14 months without it, without negative effects on safety. One of the authors is listed at the University of Alabama, Birmingham AL; the others are in Italy.
Link to the abstract is at
ncbi.nlm.nih.gov/pubmed/289...
The full text of the report can be downloaded or read from
researchgate.net/publicatio...
As background, I read that docetaxel, also a taxane, was originally used with prednisone, and that the CHARTEED trial proved docetaxel worked as well without prednisone. I wonder if this was the impetus for the work concerning Cabazitaxel.